ESR1 and non-small cell lung carcinoma: Furthermore, it has been reported that E2 directly affects IFN-γ promoter activity (63).These findings support a mechanistic link between hormonal signaling and immune checkpoint regulation, which may be particularly relevant in NSCLC tumors expressing high levels of ERα.